The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125213561 12521356 1 I 20160523 20160701 20160701 EXP JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-118829 RANBAXY 0.00 C Y 0.00000 20160701 OT GB JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125213561 12521356 1 PS VALPROIC ACID. VALPROIC ACID 1 Transplacental 600 MG, DAILY 91037 600 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125213561 12521356 1 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125213561 12521356 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125213561 12521356 Foetal exposure during pregnancy
125213561 12521356 Idiopathic generalised epilepsy

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found